CME Group upgraded at Goldman

|About: CME Group Inc. (CME)|By:, SA News Editor

No details are available, but the reasoning probably isn't too tough to fathom. If volatility is ratcheting higher - be it stocks, rates, forex, or commodities - CME Group (NASDAQ:CME) stands to benefit.

Goldman upgrades to Buy from Neutral. The $180 price target suggests 14% upside.

Shares +0.9% premarket to $159

Subscribe for full text news in your inbox